The race is on to develop therapeutic cancer vaccines that could give immunotherapies an edge, and late-stage trials could ...

Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in ...

David Israel Reynoso made his Broadway debut in March designing the costumes for the hit musical 'Water for Elephants' ...

In Australia, GPs offer flu vaccines for all ages, while flu vaccination is also available at pharmacies, generally from age ...

There are two new COVID-19 variants circulating, posing a threat to a summer surge. Is your last vaccine dose still ...

Scientists have said they believe the outbreak is more widespread based on U.S. Food and Drug Administration findings of H5N1 particles in about 20% of retail milk samples. Roughly 1 in 8 US adults ...

The FDA has approved a liquid mycophenolate to prevent organ rejections but delayed the approval of Moderna’s RSV vaccine.

As the coronavirus disease 2019 (COVID-19) continues to cause illness, you might have questions about COVID-19 vaccines. Find out about the different types of COVID-19 vaccines, how they work, the ...

Novavax (NASDAQ:NVAX) shares surged by 128% intra-day today fueled by a significant multi-billion dollar deal with French ...

A licensing deal worth potentially up to $1.2 billion with Sanofi SA has breathed new life into Novavax Inc., which has ...

AstraZeneca was the first to arrive in Kenya and is said to have saved the lives of nearly seven million people.

Moderna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to "administrative constraints" ...